Vestmark Advisory Solutions Inc. Raises Stock Position in UnitedHealth Group Incorporated $UNH

Vestmark Advisory Solutions Inc. increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,103 shares of the healthcare conglomerate’s stock after acquiring an additional 1,942 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in UnitedHealth Group were worth $4,400,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. HHM Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after acquiring an additional 26 shares during the period. Brogan Financial Inc. boosted its stake in UnitedHealth Group by 3.4% during the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after purchasing an additional 27 shares during the period. West Wealth Group LLC increased its stake in UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after purchasing an additional 27 shares during the period. Hemington Wealth Management raised its stake in UnitedHealth Group by 2.5% during the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after acquiring an additional 28 shares during the last quarter. Finally, Tlwm grew its stake in shares of UnitedHealth Group by 1.0% in the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock valued at $1,433,000 after purchasing an additional 28 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. TD Cowen increased their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Finally, Jefferies Financial Group upped their price objective on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Stock Performance

NYSE UNH opened at $324.29 on Friday. The business has a 50 day moving average price of $345.84 and a 200 day moving average price of $322.64. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The company has a market capitalization of $293.75 billion, a P/E ratio of 16.93, a PEG ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the prior year, the company earned $7.15 earnings per share. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.